Printer Friendly

STEM CELL FIRM IN EXPANSION DEALS.

Byline: NEIL HODGSON

BIOEDEN, the Daresbury-based stem cell technology firm, has announced two new agency agreements with partners in Spain and Greece.

They follow a similar deal in Jordan last November as part of the global expansion plans for the company which harvests stem cells from baby milk teeth that can be used later to tackle possible disorders such as Parkinsons and Alzheimer''s in their families by growing new nerve tissue from the cells.

Sevibe Cells in Barcelona and Procell in Athens will collect milk teeth and forward them to BioEden's laboratories at Daresbury Science & Innovation Park for storage.

Eloi Pala Ramos, Sevibe chief executive, said: "Saving stem cells from children's teeth is simple and straightforward and the demand from customers in Spain is very exciting."

Procell chief executive Dr Ema Anastasiadou added: "The ability to save these important and valuable tooth cells is something I believe everyone should consider because they offer huge potential for the future treatment of illnesses and diseases."

Jim Curtis, BioEden managing director, said: "The significance of these new European relationships is emphasised by the value of the markets.

"More than 15% of live births collect stem cells from umbilical cord blood in Spain and Greece. In the UK the figure remains at well below 1%.

"The market potential is huge with children losing their teeth naturally every day."
COPYRIGHT 2010 MGN Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:Liverpool Echo (Liverpool, England)
Date:Jan 11, 2010
Words:224
Previous Article:Seddon contract.
Next Article:Marvellous wheel; You Say Email:letters@liverpoolecho.co.uk.
Topics:


Related Articles
Key gene that protects against leukaemia identified.
Stem cell therapy may help treat corneal blindness, vision impairment.
Stem cells with ability to regenerate injured liver tissue identified.
Gene therapy 'helps minimize risk linked to stem cell transplantation'.
Activated stem cells in damaged lungs springboard to cancer progression.
Turning off oncogene may inhibit lung cancer stem cells' growth.
STEM CELL FIRM IN NEW AGENT DEAL.
New deals in Spain and Greece help stem cell specialist expand.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters